Brian Conway
Impact in
- Hepatology top 0.5%
- Hepatitis C virus research
- Virology top 2%
- HIV Research and Treatment
Papers in
- Hepatology 50
- Hepatitis C virus research 50
-
- HIV/AIDS drug development and treatment 28
- HIV/AIDS Research and Interventions 11
- Co-authors
- Jason Grebely (24 shared papers)Jesse D. Raffa (12 shared papers)Mark Tyndall (5 shared papers)Fiona Duncan (10 shared papers)Krista Genoway (6 shared papers)Mel Krajden (5 shared papers)Stanley DeVlaming (9 shared papers)Calvin Lai (2 shared papers)
- Journals
- JAIDS Journal of Acquired Immune Deficiency Syndromes (7 papers)Journal of Hepatology (7 papers)Clinical Infectious Diseases (6 papers)HIV Clinical Trials (4 papers)International Journal of Drug Policy (4 papers)
- Partner nations
- CanadaUnited StatesAustralia
In The Last Decade
Brian Conway
83 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 88
- Hepatology 1.1k
- Virology 353
- Infectious Diseases 567
- Epidemiology 839
- Emergency Medicine 71
Countries citing papers authored by Brian Conway
This map shows the geographic impact of Brian Conway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Conway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Conway more than expected).
Fields of papers citing papers by Brian Conway
This network shows the impact of papers produced by Brian Conway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Conway. The network helps show where Brian Conway may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian Conway, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 166 | |
| 2 | 2011 | 140 | |
| 3 | 2006 | 132 | |
| 4 | 2006 | 115 | |
| 5 | 2004 | 106 | |
| 6 | 2010 | 103 | |
| 7 | 2007 | 89 | |
| 8 | 2007 | 87 | |
| 9 | 2004 | 78 | |
| 10 | 2009 | 74 | |
| 11 | 2007 | 65 | |
| 12 | 2010 | 59 | |
| 13 | 2001 | 52 | |
| 14 | 2017 | 51 | |
| 15 | 2017 | 41 | |
| 16 | 2018 | 37 | |
| 17 | 2011 | 34 | |
| 18 | 2010 | 34 | |
| 19 | 2013 | 33 | |
| 20 | 2008 | 29 |
About Brian Conway
Brian Conway is a scholar working on Hepatology, Infectious Diseases, Epidemiology, Virology and Emergency Medicine, having authored 86 papers that have together received 2.1k indexed citations. Recurring topics across this work include Hepatitis C virus research (50 papers), HIV/AIDS drug development and treatment (28 papers), Hepatitis B Virus Studies (15 papers), Liver Disease Diagnosis and Treatment (13 papers), HIV Research and Treatment (13 papers), HIV/AIDS Research and Interventions (11 papers), HIV, Drug Use, Sexual Risk (6 papers) and HIV-related health complications and treatments (4 papers). The work is most often cited by research in Hepatology (1.1k citations), Virology (353 citations), Infectious Diseases (567 citations), Epidemiology (839 citations) and Emergency Medicine (71 citations). Brian Conway has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Jason Grebely, Jesse D. Raffa, Mark Tyndall, Fiona Duncan, Krista Genoway, Mel Krajden, Stanley DeVlaming, Calvin Lai, Mark Viljoen and Milan Khara. Their work appears in journals such as JAIDS Journal of Acquired Immune Deficiency Syndromes, Journal of Hepatology, Clinical Infectious Diseases, HIV Clinical Trials and International Journal of Drug Policy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.